Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.

Essence of Life 1A

The only Belgian specialist of phytotherapy and aromatherapy for pets and horses
Key Investment Information Sheet Terms & Conditions
€10,000
total amount raised in round

A full head of projects and growing development


Since the launch of the business, EOL Belgium has enjoyed continuous growth, with a marked trend through to 2021. The year 2020, marked by the COVID crisis, was paradoxically very favorable, generating exceptional sales.

After a peak in 2021, a temporary dip is observed in 2022, followed by a gradual and relatively linear recovery. Projections to 2027 confirm this upward momentum, with a target of a near-tripling of sales between 2023 and 2027.




Evolution et projection EOL



Controlling margins and optimizing costs


Since the company was founded, particular attention has always been paid to margins. From the outset, the company has been able to achieve profitability, thanks to a rigorous and precise approach to calculating margins.

Now, in 2025, we are continuing our efforts to keep production costs under control, while maintaining our high standards of quality.


Economies of scale and retail prospects


New economies of scale are emerging, which will enable us to anticipate the arrival of new retail prospects more serenely.

Our projection for the current year is therefore realistic, all the more so as discussions are currently underway with several major retail chains interested in our products.

Two of these projects are at an advanced stage, notably in the form of private labels. We believe this strategic positioning is particularly well-suited to significantly increase our volumes.

We have therefore chosen to prioritize the development of production, while limiting the marketing costs associated with the EOL brand.


Sales development: trade shows and geographic expansion


To support our growth, we are also stepping up our presence at trade shows. We have already taken part in leading industry events such as :

  • ANIDO in Kortrijk (Belgium)
  • SPOGA HORSE in Germany

Our next stop will be the DIBEVO trade show in the Netherlands, which represents a key opportunity to establish promising retail contacts.


Expansion into Flanders


Last but not least, in 2025 we will be expanding into Flanders, after an initial focus on Wallonia.
To this end, we have just recruited Noa, who will be in charge of active prospecting in this new strategic zone.


Réseau de distribution EOL

Use of funds 


The items below show the main cash requirements, both to stabilize the current situation and to anticipate future developments.
Continuing to innovate is vital to the company's long-term future. To do this, we absolutely must stabilize our financial situation, so that we can concentrate fully on our commercial and strategic development!
 
Cash flow: Current suppliers (value of stock to be financed): €50,000 (25%)
- Inventory increase: €25,000 (12.5%)
- Current customer receivables: €25,000 (12.5%)

Sales force & logistics :
- Hire order picker (PFI or Flexi Job): €12,000 (6%)
- Sales force recruitment for Flanders: 6 months' remuneration before reaching profitability: 36,000 € (18%)

Purchase of equipment :
- Purchase of electric pallet truck: €10,000 (5%)
- Label printer: €5,000 (2.5%)

Research & development :
- Development of new innovative products and products such as healthy snacks for dogs: 27,000 € (13.5%)
- Invoicing and stock management software (ODOO): €10,000 (5%)



CONCLUSION


After operating for 7 years without opening up our capital, we now need to take this step to move forward and, above all, give ourselves a good boost to get off the ground and get ahead in this highly competitive, fast-moving market!

Raise summary

Crowd investments €10,000
Committed by others €0
Amount raised €10,000
Minimum round €25,000
Maximum round €200,000
Shares in the company (total round) 21.053%
Pre-money valuation €750,000
Post-money valuation min. €775,000
Post-money valuation max. €950,000